INHIBITION OF THE P66/P51 FORM OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE BY TRANSFER RNALYS

被引:48
|
作者
BORDIER, B [1 ]
TARRAGOLITVAK, L [1 ]
SALLAFRANQUEANDREOLA, ML [1 ]
ROBERT, D [1 ]
THARAUD, D [1 ]
FOURNIER, M [1 ]
BARR, PJ [1 ]
LITVAK, S [1 ]
SARIHCOTTIN, L [1 ]
机构
[1] CHIRON CO, EMERYVILLE, CA USA
关键词
D O I
10.1093/nar/18.3.429
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human immunodeficiency virus (HIV) reverse transcriptase (RT) uses host tRNALys partially annealed to the primer binding site (PBS) as primer for the initiation of cDNA synthesis. When assaying cDNA synthesis with a template-primer complex formed by an RNA fragment carrying the PBS site and bovine tRNALys we noticed that an excess of primer tRNA inhibited strongly the DNA polymerase activity of a recombinant HIV RT (p66-p51 heterodimeric form) produced in transformed yeast cells. The same inhibitory effect was observed with animal DNA polymerase α, while avian retrovirus RT was neither affected by tRNALys nor by its specific primer tRNATrp. Although the strongest inhibition was observed with tRNALys, other tRNas like tRNAPhe and tRNATrP inhibited also the HIV RT, whereas tRNAs specific for valine, proline and glycine had no effect on enzyme activity. Digestion of tRNALys with pancreatic RNase abolished the inhibition ; on the other hand T1 RNase digestion had no effect on the inhibition suggesting a role of the anticodon region in this effect. The 12- and 14-mers corresponding to the anticodon regions of the three bovine tRNALys isoacceptors inhibited RT activity, indicating that at least an important part of the inhibitory effect could be ascribed to this tRNA region. A strong stimulation of DNA polymerase activity was observed when the effect of tRNALys was assayed on a recombinant HIV reverse transcriptase produced in a protease deficient yeast strain, which leads to the production of an active p66 enzyme. The same tRNAs that inhibited strongly the heterodimeric form stimulated the p66 form of HIV reverse transcriptase. The results suggest that although both enzymatic forms are able to interact with tRNALys the topography, as well as the functional implications of the interaction between the precursor and the mature form of HIV reverse transcriptase with the tRNALys primer, are different. © 1990 Oxford University Press.
引用
收藏
页码:429 / 436
页数:8
相关论文
共 50 条
  • [41] MISINCORPORATION AND MISPAIRED PRIMER EXTENSION BY HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    ZINNEN, S
    HSIEH, JC
    MODRICH, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (39) : 24195 - 24202
  • [42] HALOACETAMIDOTHYMIDINES AS POTENTIAL AFFINITY LABELS OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    NEENAN, JP
    SNYDER, MJ
    NELLIS, JA
    ADAMS, EW
    FASEB JOURNAL, 1995, 9 (06): : A1279 - A1279
  • [43] ACTIVE-SITE STUDIES OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    MITCHELL, LLW
    COOPERMAN, BS
    BIOCHEMISTRY, 1992, 31 (33) : 7707 - 7713
  • [44] THE INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE BY AVAROL AND AVARONE DERIVATIVES
    LOYA, S
    HIZI, A
    FEBS LETTERS, 1990, 269 (01) : 131 - 134
  • [45] Expression of the C-terminus of HIV-1 reverse transcriptase p66 and p51 subunits as a single polypeptide with RNase H activity
    Zúñiga, R
    Sengupta, S
    Snyder, C
    Leon, O
    Roth, MJ
    PROTEIN ENGINEERING DESIGN & SELECTION, 2004, 17 (07): : 581 - 587
  • [46] PURIFICATION AND CHARACTERIZATION OF HETERODIMERIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE PRODUCED BY INVITRO PROCESSING OF P66 WITH RECOMBINANT HIV-1 PROTEASE
    CHATTOPADHYAY, D
    EVANS, DB
    DEIBEL, MR
    VOSTERS, AF
    ECKENRODE, FM
    EINSPAHR, HM
    HUI, JO
    TOMASSELLI, AG
    ZURCHERNEELY, HA
    HEINRIKSON, RL
    SHARMA, SK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (20) : 14227 - 14232
  • [47] ANTIBODY THAT INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE AND ASSOCIATION WITH INABILITY TO ISOLATE VIRUS
    SANO, K
    LEE, MH
    MORALES, F
    NISHANIAN, P
    FAHEY, J
    DETELS, R
    IMAGAWA, DT
    JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (12) : 2415 - 2417
  • [48] INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED REVERSE-TRANSCRIPTASE BY AMINOACRIDINES
    ATSUMI, S
    MURAOKA, Y
    NOGAMI, T
    HOSHINO, H
    TAKEUCHI, T
    UMEZAWA, K
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1988, 14 (12) : 719 - 722
  • [49] Novel electrophoretic-tag-based in vitro assay to quantify dimerization of p66 and p51 subunits of HIV-1 reverse transcriptase (RT)
    Gupta, S.
    Dua, R.
    Nhonthachit, P.
    Fransen, S.
    McCann, D.
    Petropoulos, C. J.
    Parkin, N. T.
    Huang, W.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S156 - S156
  • [50] Novel electrophoretic-tag-based in vitro assay to quantify dimerization of p66 and p51 subunits of HIV-1 reverse transcriptase (RT)
    Gupta, S.
    Dua, R.
    Nhonthachit, P.
    Fransen, S.
    McCann, D.
    Petropoulos, C. J.
    Parkin, N. T.
    Huang, W.
    ANTIVIRAL THERAPY, 2007, 12 : S156 - S156